Governance

Steering Committee 

The ShigOraVax project Steering Committee (SC) is responsible for the scientific and technical coordination of the project and is the ultimate decision-making body of consortium. The SC is composed of the Coordinator (EVI), as well as of one representative of each partner.

The SC is responsible for:

  • Monitoring the progress of the overall strategic objectives of the consortium

  • Ensuring the effectively implementation of the work programme to achieve the deliverables and milestones

  • The financial allocation and distribution of the project resources

  • Decision about publications, dissemination, ethical issues, data protection and Intellectual Property rights

  • Acceptance of new partners in the consortium

  • The appointment of the scientific ethics advisory committee and other committees

SC Members:

Dr Sophie Houard, European Vaccine Initiative, Germany     Learn more >>>

Dr Meta Roestenberg, Leiden University Medical Center, The Netherlands     Learn more >>>

Dr Sodiomon Bienvenu Sirima, Groupe de Recherche Action en Santé, Burkina Faso     Learn more >>>

Dr Roma Chilengi, Centre for Infectious Disease Research in Zambia, Zambia     Learn more >>>

Prof Dr Jan Holmgren, University of Gothenburg, Sweden     Learn more >>>

Dr Khalid Ali Syed, Hilleman Laboratories, India     Learn more >>>

Join European Vaccine Initiative mailing list for updates on projects, training and funding opportunities

  • LinkedIn - White Circle
  • Twitter - White Circle

This project is part of the EDCTP2 Programme supported by the European Union (RIA2018V-2308)